Healthcare provider profile · identity verified

Dorota M. Andraski, MD

Internal Medicine · MONROE, WI · NPI 1780605717

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	800	215
Levothyroxine Sodium	Levothyroxine Sodium	502	110
Simvastatin	Simvastatin	445	112
Lisinopril	Lisinopril	426	112
Amlodipine Besylate	Amlodipine Besylate	381	107
Omeprazole	Omeprazole	376	99
Hydrochlorothiazide	Hydrochlorothiazide	328	95
Losartan Potassium	Losartan Potassium	281	70
Metoprolol Succinate	Metoprolol Succinate	276	79
Atenolol	Atenolol	233	56
Warfarin Sodium	Warfarin Sodium	199	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	184	41
Mirtazapine	Mirtazapine	181	36
Gabapentin	Gabapentin	179	47
Tramadol Hcl	Tramadol Hcl	177	33
Rosuvastatin Calcium	Rosuvastatin Calcium	170	45
Metformin Hcl Er	Metformin Hcl	166	44
Famotidine	Famotidine	157	33
Furosemide	Furosemide	153	52
Albuterol Sulfate Hfa	Albuterol Sulfate	150	49
Meloxicam	Meloxicam	150	45
Metoprolol Tartrate	Metoprolol Tartrate	146	37
Sertraline Hcl	Sertraline Hcl	143	34
Potassium Chloride	Potassium Chloride	130	23
Metformin Hcl	Metformin Hcl	113	32
Trazodone Hcl	Trazodone Hcl	111	27
Eliquis	Apixaban	110	26
Carvedilol	Carvedilol	103	28
Prednisone	Prednisone	103	46
Pantoprazole Sodium	Pantoprazole Sodium	101	25
Alendronate Sodium	Alendronate Sodium	99	29
Paroxetine Hcl	Paroxetine Hcl	93	20
Celecoxib	Celecoxib	91	22
Lorazepam	Lorazepam	85	25
Montelukast Sodium	Montelukast Sodium	85	23
Duloxetine Hcl	Duloxetine Hcl	83	24
Buspirone Hcl	Buspirone Hcl	77	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	15
Ozempic	Semaglutide	77	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	66	13
Allopurinol	Allopurinol	64	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	14
Fluticasone Propionate	Fluticasone Propionate	62	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	24
Xarelto	Rivaroxaban	61	14
Escitalopram Oxalate	Escitalopram Oxalate	60	15
Oxybutynin Chloride Er	Oxybutynin Chloride	58	13
Alprazolam	Alprazolam	57	11
Pravastatin Sodium	Pravastatin Sodium	56	17
Bupropion Xl	Bupropion Hcl	52	12
Glipizide Er	Glipizide	52	16
Citalopram Hbr	Citalopram Hydrobromide	50	14
Diclofenac Sodium	Diclofenac Sodium	50	13
Spironolactone	Spironolactone	49	18
Glimepiride	Glimepiride	44	suppressed
Chlorthalidone	Chlorthalidone	41	12
Esomeprazole Magnesium	Esomeprazole Magnesium	41	11
Novolog Flexpen	Insulin Aspart	40	11
Nifedipine Er	Nifedipine	39	suppressed
Benazepril Hcl	Benazepril Hcl	35	suppressed
Clonidine Hcl	Clonidine Hcl	35	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	11
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Valsartan	Valsartan	34	suppressed
Lovastatin	Lovastatin	33	suppressed
Mounjaro	Tirzepatide	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Glipizide	Glipizide	31	suppressed
Baclofen	Baclofen	29	suppressed
Jardiance	Empagliflozin	29	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	28	suppressed
Solifenacin Succinate	Solifenacin Succinate	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	26	25
Levetiracetam	Levetiracetam	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	25	16
Estradiol	Estradiol	25	suppressed
Tresiba Flextouch U-200	Insulin Degludec	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Topiramate	Topiramate	23	suppressed
Methotrexate	Methotrexate Sodium	22	suppressed
Temazepam	Temazepam	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	15
Valacyclovir	Valacyclovir Hcl	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Nystatin	Nystatin	19	13
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Humulin R	Insulin Regular, Human	16	suppressed
Ketoconazole	Ketoconazole	16	12
Memantine Hcl	Memantine Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Humulin N	Insulin Nph Human Isophane	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Sulfasalazine	Sulfasalazine	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Naproxen	Naproxen	12	suppressed
Risperidone	Risperidone	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error